SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 278.36 |
| Enterprise Value ($M) | 134.60 |
| Book Value ($M) | 135.57 |
| Book Value / Share | 1.65 |
| Price / Book | 2.05 |
| NCAV ($M) | 135.57 |
| NCAV / Share | 1.65 |
| Price / NCAV | 2.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.85 |
| Current Ratio | 11.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 148.07 |
| Assets | 148.07 |
| Liabilities | 12.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -53.04 |
| Net Income | -47.51 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -27.79 |
| Cash from Investing | 0.00 |
| Cash from Financing | 29.65 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.31 | 5.22 | |
| 13G/A | BlackRock Inc. | 8.10 | 19.59 | |
| 13G/A | State Street Corp | 4.44 | -37.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 135,263 | 673,472 | 20.08 | |
| 193,877 | 1,014,225 | 19.12 | |
| 316,377 | 746,017 | 42.41 | |
| 322,977 | 426,351 | 75.75 | |
| 233,012 | 367,021 | 63.49 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATRA – Atara Biotherapeutics, Inc. | AVIR – Atea Pharmaceuticals, Inc. |
| AVRO – AVROBIO, Inc. | BBIO – BridgeBio Pharma, Inc. |
| BCRX – BioCryst Pharmaceuticals, Inc. |